Pharma L-Aspartic Acid BP/EP Grade from Canada
European Pharmacopoeia (EP) and British Pharmacopoeia (BP) compliant L-aspartic acid for medicinal use. HTS 2922.49.49.15 applies to this chemically defined L-amino acid used in injectables and oral meds. Meets ICH Q7 GMP standards for API manufacturing.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.6095.8%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• File Drug Master File (DMF) prior to import for FDA-regulated pharma entries
• Include EP/BP monograph compliance cert; microbial limits critical for sterile use
• Validate chiral purity via polarimetry to distinguish from racemic mixtures